This episode of the Agilent Podcast Series investigates what is now being coined as ‘the golden age of cancer research’, while exploring ongoing milestones, scientific advancements, and the dedicated efforts being made to help improve patient outcomes.

This episode of the Agilent Podcast Series investigates how manufacturers and testing labs can keep up with an evolving market, how labs ensure the safety and quality of cannabis & hemp-based products, and how eco-friendly strategies can be implemented to support the cannabis & hemp testing market whilst reducing its environmental impact.

This episode of the Agilent Podcast Series investigates how global organizations are striving towards a greener planet by developing eco-friendly innovations and implementing more sustainable practices to reduce carbon emissions and tackle climate change.

As we progress further into a digital era, new research and developments into data science are constantly evolving to advance accuracies and efficiencies across various applications. Focusing specifically on scientific labs, processes and workflows have drastically improved over recent decades to facilitate the work of lab analysts due to the applications of techniques and tools encompassing artificial intelligence (AI), machine learning (ML), data science and human-computer interaction. This episode of the Agilent Podcast Series will investigate different avenues into what is known as the digital lab of the future and it will take a closer look at the broader revolution of AI.

In 2019, the global food and grocery market was valued at USD 11.7 trillion and is anticipated to increase at a CAGR of 5% from 2020-2027. As a massive part of global industry, the food we eat is not only critical to our economy and our health, but also a huge factor in our quality of life. It not only nourishes our bodies, but also brings people together, carries on traditions and evokes nostalgia. This episode of the Agilent podcast will take a closer look at what we are consuming in order to try to shed light on the science behind the food we eat.

At the start of 2020, the world began to face the hard-hitting reality of a viral pandemic: the SARS-CoV-2 virus causing COVID-19 disease. In this episode, we explore how scientific communities are learning to overcome the impacts of COVID-19, from efforts to investigating the complexity of the SARS-CoV-2 spike proteins for research purposes to transformations in the world of digital business and a deeper understanding of interventions to prevent pandemics in future.

We are faced with an ever-increasing number of environmental threats. From a changing climate and rising sea levels to pollutants in our oceans and our drinking water, environmental threats have the potential to impact not only our environment's health but also human health. In this episode, we hear directly from experts working at the forefront of research on environmental contaminants and severe weather events to better understand the potential impact of environmental threats on human health.

Integrity guides our sense of unity, honesty and morality. While it may seem a bit abstract, there are clear examples of how integrity can guide our work. Join Agilent in this episode to discover the amazing work that can be achieved when the value of integrity is respected across three distinct fields of work.

Within the area of Life Sciences, people work tirelessly around the world to solve the most pressing issues in human healthcare. One way that the industry tackle these near insurmountable issues is by assembling individuals or organizations with specific expertise to form strong partnerships. Join Agilent in this episode to hear more about the partnerships that are accelerating our perceptions of what is possible, for a better future.

Vision is arguably one of our most treasured senses; it allows us to see and make sense of the world around us. It refers to our ability to think about or plan the future with imagination or wisdom. Having vision is a common theme between all of the leading companies we speak to on this podcast.

From food waste to plastic, from green building to education, the idea of a sustainable future is a hot topic. In this latest episode, we will explore the idea of a sustainable future with respect to food production and consumption, green building development, and also look at sustainability as the new frontier for innovation within the scientific community. Interviewees include: Neil Rees, Vice President, Workplace Services Organization, Agilent Technologies.; Catriona Brady, Head of Better Places for People, World Green Building Council.; Jessica Perkins, Director of Sustainability, Apeel Sciences.

From the 'big ideas' that can change the world, through to the approaches we use to discover them, join Agilent in this podcast as we explore the meaning of the word innovation, and the significance of innovation in practice. Hear from the experts, entrepreneurs and business leaders as they discuss the meaning of innovation, its challenges, and what innovation in practice looks like. Interviewees include: Erik Micheelsen, from the Innovation Embassy in Denmark; Professor Arturo Keller from UC Santa Barbara; Darlene Solomon, senior vice president and chief technology officer, Agilent.

An in-depth look into what space means to scientists by exploring the work its customers and collaborators are doing in the research of gravitational waves, as well as the significance of space innovation in the research lab setting, and the design of laboratory equipment. Interviewees include: Dan Watch from the architecture firm Perkins and Will, who says efficient labs should have flexible building designs for optimal usage of space, 3D modelling, and open concept layouts; Shane Tichy, R and D Manager for Agilent's LC/MS Single and Triple Quadrupole business, who says that the most important thing to note when designing and developing lab equipment is to make them as compact as possible without compromising efficiency, which they achieved with the Ultivo Triple Quadrupole LC/MS mass spectrometer.

How have developments in research, drug development and management created new paradigms in the diagnosis and treatment of cancer and what this could mean for the future. Interviewees include: Dr Carlos Cordon-Cardo, a physician-scientist known widely for his research in experimental pathology and molecular oncology at the Icahn School of Medicine at Mount Sinai; Brian Dranka, Ph.D., Manager of Biology, Agilent Cell Analysis Division; Hans Christian Peterson, Director of Scientific Affairs at Dako, Agilent Pathology Solutions.